This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Index funds and ETFs offer low-cost, diversified exposure to the market. This intro explains how they differ and when each might suit your investing goals.
28,379 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
As global tensions rise, borrowing costs and lenders' risk appetites shift. This guide explains why the housing marke...
Stellantis has laid out a multi-year, multi-pillar plan to reboot profitability. The real value may come from a surpr...
Two aviation giants, Delta Air Lines and United Airlines, compete for your portfolio. This guide breaks down their bu...
June 2026’s crypto rout erased about $62 billion in market value from public firms with Bitcoin on the balance sheet,...
NVIDIA is expanding beyond GPUs into CPU territory, signaling a major strategic shift. This article explains what tha...
Aztec Labs is investigating a $2 million security incident linked to a legacy payments module. The project says there...
Public backlash to data centers has spread beyond host towns, threatening timelines and budgets as tech companies dea...
Vitalik Buterin has resumed selling ETH, logging new multi-million transfers as ether struggles to stay above the $2,...
A large IRA move at 63 can trigger higher Medicare premiums for years, thanks to a two year income lookback. Near ret...
Federal Reserve Governor Christopher Waller argued that the February payrolls report, not a Supreme Court tariff ruli...
Strategy increases its USD cash pile by $450 million via a stock offering, bringing total USD reserves to $3 billion ...